Sara Edith Mireles Hernández

Sara Edith Mireles Hernández

Auto-generated profile, based on publicly available information

Sara Edith Mireles Hernández

Neurología. Instituto Nacional de Neurología y Neurocirugía. Ciudad de México

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023
Verified
Journal Article
Open access
JHJosé Fernando García Hernández
José Fernando García Hernández
SHSara Edith Mireles Hernández
Sara Edith Mireles Hernández
José Fernando García Hernández*, Sara Edith Mireles Hernández**

7 September 2022 in Archivos de Neurociencias
Verified
Journal Article
Open access
PDF file
JESUS RAMIREZ-BERMUDEZJESUS RAMIREZ-BERMUDEZ
JESUS RAMIREZ-BERMUDEZ
JGJavier Andrés Galnares-Olalde
Javier Andrés Galnares-Olalde
AGAlexis García-Sarreón
Alexis García-Sarreón
KRKarla Rodríguez-Jiménez
Karla Rodríguez-Jiménez
SMSara Mireles
Sara Mireles
JLJuan Carlos López-Hernández
Juan Carlos López-Hernández
Background: Brain 18 FDG PET is very useful in the diagnosis of autoimmune encephalitides against post-synaptic receptors. However, little is known about the metabolic changes in other autoimmune encephalitides, such as Bickerstaff stem encephalitis (BBE). Objective: to report the case of a patient with BBE with an 18 FDG PET study and to review the literature. Results: A 20-year-old man with no relevant history presented to the emergency department due to a clinical picture of 7 days of evolution, characterized by non-painful distal paresthesias in the 4 extremities, diplopia, instability on gait and dysphagia. On the day of his hospital stay, he presented alterations in his awake state. The clinical diagnosis of Bikerstaff's stem encephalitis was made. In his paraclinical tests, the cerebrospinal fluid was normal. He received treatment with human immunoglobulin (2 grams/kg) for 5 days. An 18 FDG PET study reported hypermetabolism in the putamen and bilateral caudate nucleus and bilateral occipital hypometabolism. Conclusion: brain 18-FDG PET may be a subrogate marker for understanding CNS compromise in BBE.

7 September 2022 in Archivos de Neurociencias
Verified
Journal Article
Open access
PDF file
JESUS RAMIREZ-BERMUDEZJESUS RAMIREZ-BERMUDEZ
JESUS RAMIREZ-BERMUDEZ
JGJavier Andrés Galnares-Olalde
Javier Andrés Galnares-Olalde
AGAlexis García-Sarreón
Alexis García-Sarreón
KRKarla Rodríguez-Jiménez
Karla Rodríguez-Jiménez
SMSara Edith Mireles-Hernández
Sara Edith Mireles-Hernández
JLJuan Carlos López-Hernández
Juan Carlos López-Hernández
Background: Brain 18 FDG PET is very useful in the diagnosis of autoimmune encephalitides against post-synaptic receptors. However, little is known about the metabolic changes in other autoimmune encephalitides, such as Bickerstaff stem encephalitis (BBE). Objective: to report the case of a patient with BBE with an 18 FDG PET study and to review the literature. Results: A 20-year-old man with no relevant history presented to the emergency department due to a clinical picture of 7 days of evolution, characterized by non-painful distal paresthesias in the 4 extremities, diplopia, instability on gait and dysphagia. On the day of his hospital stay, he presented alterations in his awake state. The clinical diagnosis of Bikerstaff's stem encephalitis was made. In his paraclinical tests, the cerebrospinal fluid was normal. He received treatment with human immunoglobulin (2 grams/kg) for 5 days. An 18 FDG PET study reported hypermetabolism in the putamen and bilateral caudate nucleus and bilateral occipital hypometabolism. Conclusion: brain 18-FDG PET may be a subrogate marker for understanding CNS compromise in BBE.